ABSTRACT
INTRODUCTION
Transfer RNAs play a pivotal role in protein synthesis, providing the adaptor molecules that accomplish the translation of nucleotidyl triplet codons into amino acids in the growing polypeptide chain. During this translation process, transfer RNAs interact with many different molecules in the cell including mRNA, ribosomes, initiation and elongation factors, peptidyltRNA hydrolase, cognate aminoacyl-tRNA synthetases, and a series of tRNA modifying enzymes. All tRNAs must conform to the same general constraints for size and shape in order to fit on the ribosome, and be recognized by the translation factors. At the same time, there must be critical differences between individual tRNAs that are essential for accurate recognition by their cognate aminoacyl-tRNA synthetases in order to maintain fidelity of translation. Such common as well as individual features of the various tRNAs may reside not only in their nucleotide sequences, but also in their tertiary structures. So far, there is still no systematic view of how a tRNA is recognized by the many molecules with which it interacts (1) (2) (3) .
Recently, heterologous tRNA hyperexpression has been developed as an approach to gain insight into the structurefunction relationships of tRNA. In this system, the wild type Bacillus subtilis tRNA Tl ? gene has been cloned and hyperexpressed in Escherichia coli (4) . Upon reversed-phase HPLC fractionation of the corresponding gene products, up to four Trp-accepting peaks were revealed. Since tRNA Tr P isoacceptors in all four peaks are transcribed from the same synthetic gene sequence, it is expected that they may differ from one another with respect to post-transcriptional modifications. It is indeed well known that multiple tRNA isoacceptors separable by chromatography often result from the presence or absence of base modifications (5) (6) (7) (8) . However, other factors such as the tryptophan charging (16) and the distinct conformations of the tRNA molecule may also contribute to the differential chromatographic mobility of different isoacceptors (9, 10, 16) .
Since the cloned B.subtilis tRNA Tr P expressed inside E.coli cells would be modified by E.coli modification enzymes, it is of great interest to determine to what extent its nucleotide modificaton pattern may resemble that of endogenous E.coli tRNA Tr P. At present, no less than 37 E.coli and 16 B.subtilis tRNA sequences are known (11) . Comparison of the modified nucleotides present at various positions in these two sets of tRNA furnishes an initial basis for predicting the modified nucleotides to be found on the cloned B. subtilis tRNA Trp gene sequence shown in cloverleaf shape, all relevant modifications are arrowed at individual positions. In each bracket, two fractional numbers are included. The former is the number from E.coli tRNAs, and the latter from B.subtilis. In each fractional number, the numerator is the frequency of the modified nucleotide occurring at the specific position, while the denominator represents the number of tRNAs carrying the modified nucleotide or its precursor. The bases in B.subtilis tRNA Tlp differing from those in E.coli tRNA f are shown in bold letters.
terminus of the cloned B.subtilis tRNA Tl ? is known to prevent Trp-tRNA formation catalysed by B.subtilis Trp-tRNA synthetase (15) . The influence of this change at the discriminator base position on post-transcriptional modifications is included in the present study in order to probe the significance of this key functional residue on base-modification processes.
MATERIAL AND METHODS tRNA
Tl ? fractionation B.subtilis tRNA Tr P was hyperexpressed in E.coli and purified as described (4) . This depended on the chemical synthesis of the Bacillus subtilis tRNA Tr P gene sequence derived from the sequence of the trrvD gene cluster sequence (12) , plus a T7 promoter at the 5' end and a BstNl restriction site at the 3' end, followed by ligation of the entire fragment into the phagemid pGEM9Zf(-) (Promega Corp., USA) between the Sfil and HindUI sites. The resultant plasmid, pWWT, was cloned into Escherichia coli JM109 under the control of a lac promotor. Hyperexpression of the gene to yield B.subtilis tRNA Tl P up to 28% of total tRNA was achieved upon induction of cells in exponential growth at A 55O of 0.2 by 1 mM isopropyl 0-D-thiogalactopyranoside in minimal medium (M9-glycerol) for 4 hours. Total tRNA was extracted and fractionated by chromatography on a single Vydac C4 HPLC matrix (14) . A plasmid, pWA73, carrying a B.subtilis tRNA Tl ? mutant with guanosine replaced by adenosine at position 73 was cloned in the same way (15) and the in vivo gene product, B.subtilis tRNA Tl ? A73 mutant, was large-scale purified as for the wild type tRNA Tr P. In either instance, the HPLC tRNA fractions were collected by ethanol precipitation, or desalted and further concentrated by centrifugation in a Centricon-10 (from Amicon). The resulting tRNA samples were ryophilized. Further purification of the major peak of cloned B.subtilis tRNA 
Identification of modified nucleotides
Qualitative analysis of modified nucleotides was performed by thin layer chromatography (TLQ basically in accordance to Silberklang et al. (17) , with an additional elimination of excess 7 32 P-ATP at the end of the kinase reaction by treatment with apyrase (Sigma Grade Vm, from potato) at 10 mU/0.5 /ig tRNA for 30 minutes at 37°C (18) . The various tRNAs Tr P peaks (0.5 /ig) were first subjected to complete T2 RNase (0.05 units, from Sigma, USA) digestion to yield 3'-monophosphonucleosides, then 5'-32 P labelled using polynucleotide kinase (from Boehringer Mannheim, Germany) in the presence of y 32 P-ATP (3,000 Ci/mmole, from Amersham, England). After apyrase treatment, the 5' 32 P-,3'P-nucleoside diphosphates were treated with 1 /tg of PI RNase (from Boehringer Mannheim, Germany) to obtain 5'-32 P labelled monophosphonucleotides. Afterwards, die samples were applied to two dimensional thin layer chromatography on CEL 400 cellulose plates (Schleicher & Schuell, Germany) developed in a solvent system composed of isobutyric acid/25% NH4OH/H2O (66/1/33, by volume) in the first dimension and 0.1 M sodium phosphate pH 6.8/ammonium sulfate/n-propanol (100/60/2, V/W/V) in the second dimension prior to autoradiography. The identification of radiolabelled spots was performed by comparison with reference maps (17) (18) (19) . Confirmation of the TLC identification, as well as quantitation, of the modified nucleosides were performed by HPLC after hydrolysis of the purified tRNA T T. Each sample (20 /tg) of tRNA dissolved in 50 /d of distilled water was digested overnight to completion at 37°C by 10 y\ (0.3 U//il) of PI RNase (Boehringer Mannheim, Germany) in 30 mM acetate buffer pH 5.30, and 10 fi\ of 10 mM ZnCl 2 -The solution of free 5'-phosphate nucleotides obtained was digested by 10 /tl (0.1 U//tl) of bacterial alkaline phosphatase (BAP) (Sigma, St Louis, MO, USA) in 100 /tl of 0.5 M Tris buffer pH 8.30 at 37°C for 2 hours. The resultant hydrolysate was analyzed by HPLC using a Spectra-Physics liquid chromatograph equipped with a Spectra Focus detector (Spectra-Physics France, Les Ulis) and a Supelcosil LC 18S column, 250 mmx4.6 mm (Supelco France, St Germain en Laye). Chromatography was carried out under the conditions for separation of ribonucleosides developed by Gehrke and Kuo (20) . The instrumentation system consisted of a variable volume injector, a ternary solvent delivery system, a temperature-controlled column oven (maintaining a temperature of 26°C ± 0.2°C) and a forward scanning detector. A computer integrated the functions of each component and performed data processing, including post-run integrations as an important requirement for quantitative analysis. Each nucleoside component detected in the eluate was rigorously identified by comparison of its UV spectrum and retention time with ribonucleoside reference standards. All nucleosides present were quantified in terms of moles of residue per mole of tRNA molecule using the relative molar response (RMR) calculated for each nucleoside with Bi^G as internal standard.
In order to characterize a methylated dinucleotide (Nm-p-N') resistant to PI nuclease, digestion with snake venom phosphodiesterase (SV-PDE) was employed. The total nuclease PI-BAP digest prepared as described above as well as the dinucleotide collected from HPLC eluates were hydrolyzed by a mixture of 20 /tl of SV-PDE (0.001 U//tl), 10 /d of 10 mM magnesium acetate, and 50 /tl of 0.5 M Tris buffer pH 8.30 for 4 hours at 37°C. The hydrolysate obtained was again analyzed by the HPLC protocol described above.
RESULTS

Heterologous tRNA
Tr P isoacceptors When the wild-type B.subtilis tRNA Tl ? gene was hyperexpressed in E.coli in minimal medium, fractionation of total extracted tRNA by reversed-phase HPLC on a C4 column revealed up to four tryptophan accepting peaks, the major Peak I and the three minor Peaks n, HI and IV (Figure 2A ). These isoacceptors all migrated at same rate in denaturing 12% polyacrylamide gel ( Figure 2B ), indicating that they were all of equal length. The A73 mutant B.subtilis tRNA Tr P obtained by hyperexpression of the A73 mutant gene was also known to be of the same length as wild-type Peak I (15) .
To examine the effects of growth-medium enrichment on the distribution of the isoacceptor peaks, Bacto-yeast extract and Bacto-tryptone were added to minimal medium culture of E.coli cells carrying pWWT 210 minutes after IPTG induction. The cells were grown for another 30 minutes prior to harvesting. Under these conditions, the isoacceptor Peak I was decreased significantly, while Peak II was increased, so that Peak II instead of Peak I became the major peak (Figure 3a) . Peaks IE and IV also remained evident, but these peaks were extensively diminished when treatment of the tRNA at pH 8 was carried out to strip away any tryptophan attached to the tRNA (Figure 3b ). This suggests that Peaks IQ and IV were Trp-tRNA Tl ? rather than uncharged tRNA Tr P.
TLC identification of modified nucleotides
The TLC autoradiographs of the nucleotides of each of the four wild-type isoacceptors of B.subtilis tRNA Tl P expressed in E.coli, the A73 mutant, and native E.coli tRNA (s 4 !!) spot, between T and U on the TLC, was barely detectable, which is consistent with the known instability of this nucleotide (21) . No gross difference was evident among the four wild-type isoacceptors. Only the intensity of the N6-isopentenyladenosine/2-methylthio-N6-isopentenyl-adenosine (i A nucleoside peak eluting with a retention time of 36 minutes, and therefore referred to as N36, was observed in the PI RNase-BAP digests of all the cloned species of B.subtilis tRNA Tn> including the A73 mutant (Figures 5a-e) . After treatment with snake venom phosphodiesterase (SV-PDE), the N36 peak disappeared from the resulting hydrolysates, while the peak of Cm was significantly increased. This suggests that N36 could be a di-or oligo-nucleotide containing Cm, since such nucleotides are known to be partially resistant to PI RNase. In confirmation, the N36 compound collected from the HPLC of wild-type Peak I yielded two nucleosides in equal molar amounts upon enzymatic hydrolysis with SV-PDE followed by BAP treatment (data not shown). These two nucleosides were readily identified as 2'-Omethylcytidine (Cm) and unmodified uridine (U) based on a comparison of their HPLC retention times and UV spectra with those of authentic Cm and U nucleosides. N36 was thus characterized as Cm-p-U. The sum of the molar ratios of Cm and N36 was found to be close to 1 for each of the cloned species of B.subtilis tRNA Tl ? (Figure 6 ). Thus the variable, less than unity molar ratios of Cm could be explained by the partial hydrolysis of Cm-p-U.
DISCUSSION
Transfer RNAs undergo during their maturation extensive, diverse post-transcriptional modifications that vary with both the tRNA and the organism (23) (24) (25) . The structural elements determining the specificity of different modifying enzymes are only beginning to be elucidated. A powerful approach for defining such structural specificity is to produce tRNAs of varying sequences inside the cell, and monitor the modifications imposed on them by the modifying enzymes. To facilitate analysis, the tRNAs should be hyperexpressed, so that relatively large quantities may be purified for biochemical and biophysical investigation. The heterologous hyperexpression of B.subtilis tRNA Tr P in E.coli satisfies these requirements. In the present study, we have characterized the modification patterns of wild-type and A73 mutant B.subtilis tRNA T T produced in this system, and compared them to the patterns of native E.coli tRNA P gene transcript is not a substrate for the guanosine-7-methylase of E.coli. In this regard, it has been reported that guanosine-7-methylase actively recognizes G46 only when it is part of a 5-member extra loop (26) (27) . On this basis the inactivity of B.subtilis tRNA Tr P as a 7-methyl acceptor at G46 is probably due to G46 being a member of a 4-base extra loop, in contrast to the 5-base extra loop in the case of E.coli tRNA J>. The only likely location for these residues is position 37, the nucleotide 3' to the anticodon. The mechanism for the generation of these two nucleosides consists of a sequential conversion of A first to i 6 A, and the latter in turn to ms 2 i 6 A. Since all species of cloned B.subtilis tRNA T T contained a stoichiometric amount of N6-isopentenyl group at position-37, the i 6 A modification enzyme was not a limiting factor in E.coli. This was evidently not the case for the subsequent 2-memylthiolation of i 6 A37, which involves two modification enzymes in the formation of the hypermodified ms 2 i 6 A. Indeed, the extent of methylthiolation of A37 constituted the most prominent difference among the 4 wild-type isoacceptors. Although the exact basis for the incomplete formation of the 2-methylthiolate derivative remains to be established, at least two possibilities should be considered. First, the supply of the modifying enzymes or their cofactor(s), such as iron (28) and/or cysteine (29) , could be limiting. Secondly, the modification reaction could be regulated by growth condition (5) (6) (7) (8) 30) . Thus a shift-up of the growth medium from minimal to rich rapidly induced changes in the proportion of the different isoacceptors ( Figure 3) . The major tRNA Besides ^U at position 8, which was difficult to quantitate owing to its instability (21) , Gm is the only other modified nucleotide observed to be present at low levels (with a molar ratio of 0.2-0.3) in the cloned B.subtilis tRNA Tr P isoacceptors with the wild-type gene sequence ( Figure 5 ). This nucleotide, found in 30% of E.coli tRNAs at position 18 in the D-loop, was detected only at trace levels in E.coli tRNA It is striking that the A73 mutant B.subtilis tRNA Tr " was completely lacking in Gm (Figure 4e and 5e) , in contrast to the presence of this modification in all four wild-type isoacceptors (Figures 4a-d and 5a-d) . This raises the question of whether it is the A73 base itself, or the global tRNA three-dimensional structure which A73 may influence, that represents the important recognition element for enzymatic 2'-methylation at G18 by E.coli methylase. It is known that the G to A mutation at the discriminator position-73 of B.subtilis tRNA Tr P causes the tRNA Tr P to be inactive toward its cognate Trp-tRNA synthetase (15) . Thus the replacement of G73 by A73 brought about a loss of recognition of the tRNA Tr P by Trp-tRNA synthetase, and also a loss of recognition by die Gml8 methylase.
Since the sum of Cm and Cm-p-U (N36) was one mole per mole of tRNA It is also noteworthy that the ms 2 group at A37 occurred to varying extents in the different tRNA T T isoacceptors. This modification was fully formed in Peak n, but completely lacking in Peak I. Since this represented the main difference between Peaks I and II, it is proposed that Peak n is derived from Peak I by methylthiolation at A37. The fact that the major isoacceptor was Peak I in minimal growth medium, but Peak II in rich growth medium suggests that the incomplete methylthiolation at A37 could be the result of overproduction of cloned tRNA A might be a rate-limiting process inside the cells. Since the hydrophobicity is a major fractionating parameter for reversedphase HPLC as employed in this study, whereas the ms 2 group is known to be highly hydrophobic, the differential chromatographic behavior of tRNA Tr P Peaks I and II is probably due to the hydrophobicity difference between i 6 A37 and ms 2 i 6 A37.
Regarding the two minor peaks, Peak HI was also enriched in i 6 A compared to Peak IV, whereas the latter was relatively enriched in ms 2 i 6 A. However, these peaks, being lower in quantities than Peak I and Peak II, might be more contaminated by host cell tRNAs. The relationship between Peaks III and IV, as well as their relationships to Peaks I and n, require further clarification, although comparison of HPLC profiles of total tRN A before and after stripping of the tryptophan charge on the tRNA (Figure 3 ) suggests that Peaks m and IV are the Trpcharged forms of Peaks I and n, respectively. It is well known that tRNA Tr P could be right-shifted on the chromatogram by Trp-charging (16) . As well, a number of investigators have found that some species of tRNA can exist in a physically denatured form that is chromatographically separable from the native form (9, (33) (34) (35) . Therefore the possibility that Peaks HI and IV included some denatured forms of Peaks I and II with an altered conformation also could not be excluded.
In conclusion, when B.subtilis tRNA Tl ?was expressed in the heterologous E.coli host, its modification pattern was determined by an interplay between its own base sequence and the specificity of the host modifying enzymes. Analysis of the observed modification has served to focus on the significance of a 5-base extra-loop to the 7-methylation of G46, uncover the unexpected importance of the G73 residue to the 2'-methylation of G18, and contrast the ability of E.coli to the inability of B.subtilis enzyme systems to catalyse the formation of Cm32 and Gml8 when presented with exactly the same substrate tRNA T T sequence. These observations illustrate the utility of the heterologous expression approach, especially when quantitation of nucleoside modifications is facilitated by a hyperexpression of the cloned tRNA, in helping to unravel the complex structure-function relationships in post-transcriptional modification reactions. Such a heterologous tRNA expression system permits investigations into species specificity of post-transcriptional modification under physiological conditions in living cells.
